Introduction: The Massive Opportunity in the Indian Medical Device Market
India represents one of the fastest-growing healthcare markets in the world. Valued at approximately USD 16.16 billion in 2025 and projected to reach USD 44.76 billion by 2034 (CAGR of 12.2%), the medical device sector offers unparalleled opportunities for foreign manufacturers from the USA, Europe, China, Japan, South Korea, and beyond.
With a population exceeding 1.4 billion, expanding hospital infrastructure, rising chronic disease prevalence, and government initiatives such as Ayushman Bharat and Production Linked Incentive (PLI) schemes, demand for high-quality imported devices—ranging from diagnostic imaging and cardiovascular implants to minimally invasive surgical tools—continues to surge. Domestic production covers only basic consumables, leaving premium Class C and D technologies heavily reliant on imports.
However, market entry requires strict compliance with the Central Drugs Standard Control Organization (CDSCO) under the Medical Devices Rules, 2017 (MDR 2017). The gateway for foreign manufacturers is the MD-14 License India — the application for the official CDSCO Import License (issued as Form MD-15). Mastering this process is not just regulatory necessity; it is your fastest route to revenue in one of Asia’s most promising medtech markets.
This comprehensive guide equips international manufacturers with everything needed to navigate CDSCO Import License requirements successfully.
What is MD-14 License in India?
The MD-14 License India refers to the application submitted in Form MD-14 to the CDSCO for obtaining an Import License (granted in Form MD-15). It is the mandatory regulatory approval for foreign manufacturers to legally import medical devices into India.
Unlike manufacturing licenses, the MD-14 process is specifically designed for importers and is filed exclusively by an Authorized Indian Agent (AIA) on behalf of the overseas manufacturer via the SUGAM online portal. Once approved, the MD-15 Import License remains valid in perpetuity, subject to timely payment of retention fees every five years.
This license covers all regulated medical devices except fully exempted low-risk Class A (non-sterile, non-measuring) devices notified under G.S.R. 777(E) dated 14.10.2022. For everything else — from sterile disposables to high-risk implants — the MD-14 application is non-negotiable.
Why Foreign Manufacturers Need CDSCO Approval
India’s regulatory framework aligns with global standards while prioritizing patient safety. Without CDSCO Import License approval:
- Customs clearance is blocked.
- Legal distribution, sale, or even exhibition is prohibited.
- Penalties include product seizure, fines, and potential blacklisting.
CDSCO approval also builds credibility with Indian hospitals, distributors, and government tenders. It demonstrates that your devices meet rigorous Indian safety, performance, and quality requirements — often leveraging existing US FDA, CE Mark, or PMDA approvals through recognized Free Sale Certificates.
Step-by-Step MD-14 Application Process
- Appoint an Authorized Indian Agent (AIA) – The AIA must hold a valid wholesale license (Form 20/21B) or MD-42 registration certificate. Execute a notarized/apostilled Power of Attorney with undertaking as per Part I of the Fourth Schedule.
- Determine Device Classification – Use CDSCO risk-based lists or apply for official classification via the SUGAM portal (new provision effective 27.11.2025).
- Prepare Technical Documentation – Compile Plant Master File (PMF – Appendix I) and Device Master File (DMF – Appendix II) in full detail.
- Register on SUGAM Portal – Create an account and initiate Form MD-14 application.
- Upload Documents and Pay Fees – Submit complete dossier with online fee payment.
- CDSCO Review and Queries – Respond promptly to any queries (clock pauses during response period).
- Possible Overseas Site Inspection – CDSCO may inspect your manufacturing facility.
- Receive MD-15 Import License – Approval communicated via portal and email.
The entire process is 100% online, transparent, and trackable.
Documents Required for MD-14 License
The official CDSCO checklist (Fourth Schedule) is exhaustive. Core mandatory documents include:
- Covering letter and auto-generated Form MD-14
- Fee challan
- Power of Attorney + undertaking (authenticated by Indian Magistrate, Embassy, or Apostille)
- Wholesale license / MD-42 of the Authorized Agent
- Constitution details of the AIA
- Free Sale Certificate (FSC) from country of origin (notarized) + FSC from any GHTF country (USA, UK, EU, Canada, Japan, Australia)
- Overseas manufacturing site registration certificate
- ISO 13485 or equivalent QMS certificate (notarized)
- CE/Full Quality Assurance certificates and Declaration of Conformity
- Complete Plant Master File (Appendix I)
- Detailed Device Master File (Appendix II) covering executive summary, design, specifications, risk management, biocompatibility, sterilization validation, clinical evidence, stability data, and post-market surveillance
All foreign-language documents require notarized English translations. Grouping of devices (family/system) can reduce duplication.
Government Fees and Approval Timeline
Fees are prescribed in the Second Schedule of MDR 2017 and structured by risk class (quoted in approximate USD for international convenience; actual payment in INR via SUGAM):
| Device Class | Site Fee (per manufacturing site) | Product/Device Family Fee |
|---|---|---|
| Class A (non-sterile/non-measuring) | No fee (exempt) | No fee |
| Class A (sterile/measuring/notified) | US$1,000 | US$50 |
| Class B | US$2,000 | US$1,000 |
| Class C & D | US$3,000 | US$1,500 |
Additional costs: overseas inspection fees (actuals), retention fee every 5 years, and testing if required.
Timeline: Statutory maximum of 9 months from application date. In practice:
- Class A & B: 4–6 months
- Class C & D: 6–12 months (subject to query resolution and inspection)
Early engagement with an experienced regulatory consultant significantly accelerates approval.
Device Classification in India (Class A, B, C, D)
CDSCO follows a risk-based system under the First Schedule of MDR 2017:
- Class A (Low Risk): Bandages, surgical drapes, thermometers (non-sterile/non-measuring largely exempted).
- Class B (Low-Moderate Risk): Hypodermic needles, suction equipment, blood pressure monitors.
- Class C (Moderate-High Risk): Ventilators, infusion pumps, orthopedic implants, X-ray machines.
- Class D (High Risk): Heart valves, pacemakers, stents, implantable defibrillators.
Correct classification is critical — misclassification is the leading cause of rejection. CDSCO publishes updated lists (latest: Oncology devices, January 2026).
Role of Authorized Indian Agent
The AIA is your legal representative in India and bears regulatory responsibility for:
- Filing and maintaining the MD-14 application
- Import, storage, distribution, and post-market surveillance
- Adverse event reporting and recalls
- Liaison with CDSCO and state authorities
Choose an AIA with proven CDSCO track record, valid wholesale license, and strong logistics network. A poorly selected agent can delay approval by months or lead to compliance issues.
Common Mistakes in CDSCO Applications
- Incorrect device classification or grouping
- Incomplete or non-compliant Device Master File (missing risk analysis, clinical data, or validation reports)
- Improper Power of Attorney authentication (missing Apostille or Indian Embassy stamp)
- Inconsistent manufacturer/importer details across documents
- Outdated or non-notarized Free Sale Certificates
- Failure to respond to CDSCO queries within stipulated time
- Non-compliant labeling/IFU (must include Indian importer details and symbols per MDR 2017)
Engaging a specialist regulatory consultant eliminates these risks.
Benefits of Entering the Indian Medical Device Market
Beyond the obvious revenue potential, successful MD-14 approval delivers:
- Access to 1.4+ billion patients and 70,000+ hospitals
- Participation in government tenders and insurance schemes
- Strategic base for Asia-Pacific expansion (PLI incentives available)
- Brand credibility through CDSCO recognition
- Long-term partnerships with local distributors and KOLs
Many global leaders have achieved 20–30% YoY growth after securing CDSCO Import License approval.
FAQ Section
1. What is the difference between MD-14 and MD-15?
MD-14 is the application form; MD-15 is the actual Import License issued upon approval.
2. Can a foreign manufacturer apply directly for MD-14 License India?
No. Only an Indian Authorized Agent with valid wholesale license can submit the application.
3. How long does CDSCO Import License approval take in 2026?
Statutory timeline is 9 months; actual approval ranges from 4 months (Class A/B) to 9–12 months (Class C/D).
4. Do Class A devices require an MD-14 License?
Non-sterile, non-measuring Class A devices are largely exempted. Sterile/measuring Class A and all higher classes require full approval.
5. What are the government fees for MD-14 application?
Fees range from US$1,000–3,000 (Approx) per site plus per-device fees depending on class (see table above). Exact payment is in INR via SUGAM. contact us for more information.
6. Is clinical data mandatory for CDSCO MD-14 Application?
Yes for Class C and D devices; local clinical evidence may be required if predicate data is insufficient.
7. How do I choose the right Authorized Indian Agent?
Select an experienced partner with existing CDSCO approvals, strong compliance team, and nationwide distribution capability. Verify track record through references.
8. Can the MD-15 Import License be transferred or amended?
Changes in manufacturer, site, or agent require a fresh application. Endorsements for additional devices or sites are possible with supplementary fees.
Conclusion: Your Gateway to India’s Booming Healthcare Market
The MD-14 License India is more than paperwork — it is your passport to one of the world’s most dynamic medical device markets. With clear processes, digital portals, and alignment to international standards, CDSCO approval has never been more achievable for prepared foreign manufacturers.
By partnering with regulatory experts who understand both global quality systems and Indian nuances, you can avoid delays, reduce costs, and accelerate time-to-market.
Strong Call-to-Action
Ready to import your medical devices into India with full CDSCO compliance?
Our team of regulatory affairs consultants specializes exclusively in MD-14 License India and CDSCO Import License applications for international manufacturers. We provide end-to-end support — from Authorized Agent appointment and dossier preparation to approval and post-market compliance.
Contact us today for a free regulatory roadmap and timeline assessment tailored to your device portfolio. Secure your competitive advantage in the Indian market before your competitors do.